The Clinical Laboratory Improvement Amendments (CLIA 88) to the Clinical Laboratory Improvement Act of 1967 continues to undergo transformation since its implementation more than 2 years ago. The law and its subsequent regulatory modifications were intended to promote high quality in and accurate results from laboratory testing procedures, regardless of the site at which testing occurred. A number of federal regulatory agencies and committees such as the Healthcare Financing Administration, the Clinical Improved Amendments Committee, and the Commission on Laboratory Accreditation, as well as numerous new or modified regulations and requirements have gained importance since CLIA 88 was enacted. In this discussion, components of CLIA 88 that have the greatest impact on clinical microbiology laboratories are presented. In addition, the potential future significance of CLIA 88 are outlined.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0732-8893(95)00152-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Overview of dengue diagnostic limitations and potential strategies for improvement.
Diagnosis (Berl)
January 2025
Matrix Labs Private Limited, Chennai, Tamil Nadu, India.
Introduction: Dengue is a viral infection caused by any one of the four related dengue virus (DENV) serotypes, 1-4. DENV is a single-stranded RNA virus belonging to the genus . Dengue can cause a range of symptoms, from mild to severe life-threatening illness.
View Article and Find Full Text PDFBasophil activation test; User's manual.
J Immunol Methods
January 2025
Amerimmune LLC, 8260 Greensboro Dr, McLean VA-22102, USA. Electronic address:
Immediate allergic responses, orchestrated by basophils and mast cells, are pivotal in severe allergic reactions. The flow cytometry-based Basophil Activation Test (BAT) is a clinically important assay for testing allergic reactions using CD63 and CD203c as endpoints. The test measures the concentration dependent response to the allergens providing a functional readout of the patients' allergies.
View Article and Find Full Text PDFAnalytical Validation and Performance of a Blood-Based P-tau217 Diagnostic Test for Alzheimer Disease.
J Appl Lab Med
January 2025
Eli Lilly and Company, Indianapolis, IN, United States.
Background: Blood-based biomarkers, especially P-tau217, have been gaining interest as diagnostic tools to measure Alzheimer disease (AD) pathology.
Methods: We developed a plasma P-tau217 chemiluminescent immunoassay using 4G10E2 and IBA493 as antibodies, a synthetic tau peptide as calibrator, and the Quanterix SP-X imager. Analytical validation performed in a College of American Pathologists-accredited CLIA laboratory involved multiple kit lots, operators, timepoints, and imagers.
Role of the International Society of Liquid Biopsy (ISLB) in establishing quality control frameworks for clinical integration.
Crit Rev Oncol Hematol
January 2025
Division of Medical Oncology, The Arthur G. James Comprehensive Cancer Center, Columbus, OH, USA.
Liquid biopsy (LB) has revolutionized molecular pathology, offering non-invasive insights into tumor biology. However, widespread adoption is hindered by a lack of standardized protocols, requiring robust quality control and harmonized workflows. Large-scale studies are needed to establish effective standard operating procedures (SOPs), particularly for circulating tumor DNA (ctDNA) assays tailored to different disease stages.
View Article and Find Full Text PDFAnalytical characteristics and performance of a new hs-cTnI method: a multicenter-study.
Clin Chem Lab Med
January 2025
Coordinator of the Italian Study Group of Cardiac Biomarkers, Scuola Superiore Sant'Anna and Fondazione CNR - Regione Toscana G. Monasterio, Pisa, Italy.
Article Synopsis
- The study aimed to assess the performance and establish the upper reference limit for high-sensitivity cardiac troponin I (hs-cTnI) using the MAGLUMI CLIA method in healthy populations.
- Two groups of healthy adults were analyzed: one with younger adults (average age 43) and another with older adults (average age 78), focusing on blood donation volunteers.
- Results showed that hs-cTnI levels were significantly higher in men than women, especially after age 55, confirming that the MAGLUMI CLIA method meets international diagnostic criteria for cardiac assessments.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!